Comment on "Plasma Leptin Is Associated With Amyloid CSF Biomarkers and Alzheimer's Disease Diagnosis in Cognitively Impaired Patients"

被引:0
|
作者
Naharci, Mehmet Ilkin [1 ,2 ,3 ]
机构
[1] Univ Hlth Sci, Gulhane Fac Med, Ankara, Turkiye
[2] Univ Hlth Sci, Gulhane Training & Res Hosp, Div Geriatr, Ankara, Turkiye
[3] Saglik Bilimleri Univ, Gulhane Tip Fak, Geriatri Bilim Dali, TR-06018 Ankara, Turkiye
关键词
D O I
10.1093/gerona/glad093
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
[No abstract available]
引用
收藏
页码:1081 / 1081
页数:1
相关论文
共 50 条
  • [21] Association of CSF orexin with Alzheimer's disease biomarkers and sleep measurements in cognitively unimpaired adults
    Fernandez-Arcos, Ana
    Tort-Colet, Nuria
    Stankeviciute, Laura
    Minguillon, Carolina
    Sanchez-Benavides, Gonzalo
    Hernandez Penas, Laura
    Shekari, Mahnaz
    Holst, Sebastian
    Garces, Pilar
    Mueggler, Thomas
    Zetterberg, Henrik
    Blennow, Kaj
    Kvartsberg, Hlin
    Kollmorgen, Gwendlyn
    Quijano-Rubio, Clara
    Ninerola-Baizan, Aida
    Iranzo, Alex
    Domingo Gispert, Juan
    Luis Molinuevo, Jose
    Suarez-Calvet, Marc
    Grau, Oriol
    JOURNAL OF SLEEP RESEARCH, 2024, 33
  • [22] Longitudinal trajectories of Alzheimer's disease CSF biomarkers and blood pressure in cognitively healthy subjects
    Biskaduros, Adrienne
    Glodzik, Lidia
    Saint Louis, Leslie A.
    Rusinek, Henry
    Pirraglia, Elizabeth
    Osorio, Ricardo
    Butler, Tracy
    Li, Yi
    Xi, Ke
    Tanzi, Emily
    Harvey, Patrick
    Zetterberg, Henrik
    Blennow, Kaj
    de Leon, Mony J.
    ALZHEIMERS & DEMENTIA, 2024, 20 (07) : 4389 - 4400
  • [23] Use of CSF biomarkers in the diagnosis of Alzheimer's disease in clinical practice
    Koric, L.
    Felician, O.
    Ceccaldi, M.
    REVUE NEUROLOGIQUE, 2011, 167 (6-7) : 474 - 484
  • [24] CSF and plasma biomarkers for early Alzheimer's disease and to monitor Aβ modulation
    Blennow, Kaj
    NEUROBIOLOGY OF AGING, 2008, 29 : S2 - S2
  • [25] Plasma biomarkers for diagnosis and differentiation and their cognitive correlations in patients with Alzheimer's disease
    Sun, Wenhao
    Ye, Shuwei
    Wang, Yu
    Chen, Huifeng
    Che, Ping
    Chen, Jingshan
    Zhang, Nan
    BRAIN COMMUNICATIONS, 2025, 7 (02)
  • [26] Longitudinal study of CSF biomarkers in patients with Alzheimer's disease
    Buchhave, P.
    Stomrud, E.
    Blennow, K.
    Zetterberg, H.
    Londos, E.
    Minthon, L.
    Hansson, O.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 337 - 337
  • [27] Longitudinal Study of CSF Biomarkers in Patients with Alzheimer's Disease
    Buchhave, Peder
    Blennow, Kaj
    Zetterberg, Henrik
    Stomrud, Erik
    Londos, Elisabet
    Andreasen, Niels
    Minthon, Lennart
    Hansson, Oskar
    PLOS ONE, 2009, 4 (07):
  • [28] Amyloid biomarkers in Alzheimer's disease
    Blennow, Kai
    Mattsson, Niklas
    Scholl, Michael
    Hansson, Oskar
    Zetterberg, Henrik
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2015, 36 (05) : 297 - 309
  • [29] Plasma amyloid ® levels in alzheimer's disease and cognitively normal controls in syrian population
    Manafikhi, R.
    CLINICA CHIMICA ACTA, 2024, 558 : 20 - 21
  • [30] Association of plasma biomarkers of amyloid and neurodegeneration with cerebrovascular disease and Alzheimer's disease
    Graff-Radford, Jonathan
    Mielke, Michelle M.
    Hofrenning, Ekaterina I.
    Kouri, Naomi
    Lesnick, Timothy G.
    Moloney, Christina M.
    Rabinstein, Alejandro
    Cabrera-Rodriguez, Janisse N.
    Othberg, Darren M. R.
    Elski, Scott A. Przyb
    Petersen, Ronald C.
    Knopman, David S.
    Dickson, Dennis W.
    Jack, Clifford R.
    Algeciras-Schimnich, Alicia
    Nguyen, Aivi T.
    Murray, Melissa E.
    Vemuri, Prashanthi
    NEUROBIOLOGY OF AGING, 2022, 119 : 1 - 7